Arthur Herbst to Humans
This is a "connection" page, showing publications Arthur Herbst has written about Humans.
Connection Strength
0.413
-
Follow-up of Patients with Clear-Cell Adenocarcinoma of the Vagina and Cervix. N Engl J Med. 2018 05 03; 378(18):1746-1748.
Score: 0.021
-
Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up. Gynecol Oncol. 2017 09; 146(3):566-571.
Score: 0.020
-
Diethylstilbestrol (DES) Pregnancy Treatment: A Promising Widely Used Therapy with Unintended Adverse Consequences. AMA J Ethics. 2015 Sep 01; 17(9):865-70.
Score: 0.018
-
Influence of mode of delivery on neonatal mortality in the second twin, at and before term. BJOG. 2008 Nov; 115(12):1512-7.
Score: 0.011
-
The management of ASCUS cervical cytologic abnormalities and HPV testing: a cautionary note. Obstet Gynecol. 2001 Nov; 98(5 Pt 1):849-51.
Score: 0.007
-
Low 5-minute Apgar score: a population-based register study of 1 million term births. Obstet Gynecol. 2001 Jul; 98(1):65-70.
Score: 0.007
-
Re: van Nagell JR Jr, et al. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer. Gynecol Oncol 2000; 77: 350-6. Gynecol Oncol. 2001 Mar; 80(3):421; author reply 422.
Score: 0.007
-
Brain-specific NSE and S-100 proteins in umbilical blood after normal delivery. Clin Chim Acta. 2001 Feb; 304(1-2):57-63.
Score: 0.006
-
Risk factors for diethylstilbestrol-associated clear cell adenocarcinoma. Obstet Gynecol. 2000 Jun; 95(6 Pt 1):814-20.
Score: 0.006
-
Behavior of estrogen-associated female genital tract cancer and its relation to neoplasia following intrauterine exposure to diethylstilbestrol (DES). Gynecol Oncol. 2000 Feb; 76(2):147-56.
Score: 0.006
-
Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. 1971. Am J Obstet Gynecol. 1999 Dec; 181(6):1574-5.
Score: 0.006
-
Diethylstilbestrol and adenocarcinoma of the vagina. Am J Obstet Gynecol. 1999 Dec; 181(6):1576-8; discussion 1579.
Score: 0.006
-
Adjusting to the present: presidential address. Am J Obstet Gynecol. 1999 Apr; 180(4):779-83.
Score: 0.006
-
Reproductive and hormone-related outcomes in women whose mothers were exposed in utero to diethylstilbestrol (DES): A report from the US National Cancer Institute DES Third Generation Study. Reprod Toxicol. 2019 03; 84:32-38.
Score: 0.006
-
Risk factors for acidemia at birth. Obstet Gynecol. 1997 Jul; 90(1):125-30.
Score: 0.005
-
Prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tract. Am J Obstet Gynecol. 2016 09; 215(3):322.e1-8.
Score: 0.005
-
Self-reported allergy, infection, and autoimmune diseases among men and women exposed in utero to diethylstilbestrol. J Clin Epidemiol. 1996 Feb; 49(2):263-6.
Score: 0.005
-
Risk factors for fever in labor. Obstet Gynecol. 1995 Nov; 86(5):790-4.
Score: 0.005
-
Age at menarche among diethylstilbestrol granddaughters. Am J Obstet Gynecol. 1995 Sep; 173(3 Pt 1):835-6.
Score: 0.004
-
Fertility in men exposed prenatally to diethylstilbestrol. N Engl J Med. 1995 May 25; 332(21):1411-6.
Score: 0.004
-
Factors associated with a lack of pap smear utilization in women exposed in utero to diethylstilbestrol. J Womens Health (Larchmt). 2015 Apr; 24(4):308-15.
Score: 0.004
-
Onset of menopause in women exposed to diethylstilbestrol in utero. Am J Obstet Gynecol. 1995 Jan; 172(1 Pt 1):92-5.
Score: 0.004
-
Influence of in utero diethylstilbestrol exposure on the prognosis and biologic behavior of vaginal clear-cell adenocarcinoma. Gynecol Oncol. 1994 Nov; 55(2):238-44.
Score: 0.004
-
DES exposure: an update. Contemp Pediatr. 1994 Nov; 11(11):59-62, 64, 66 passim.
Score: 0.004
-
Human papillomavirus detection and p53 expression in clear-cell adenocarcinoma of the vagina and cervix. Obstet Gynecol. 1994 Sep; 84(3):404-8.
Score: 0.004
-
Association of physical activity with glycaemic control and cardiovascular risk profile in 65 666 people with type 2 diabetes from Germany and Austria. Diabet Med. 2014 Aug; 31(8):905-12.
Score: 0.004
-
The epidemiology of ovarian carcinoma and the current status of tumor markers to detect disease. Am J Obstet Gynecol. 1994 Apr; 170(4):1099-105; discussion 1105-7.
Score: 0.004
-
Effects on the menstrual cycle of in utero exposure to diethylstilbestrol. Am J Obstet Gynecol. 1994 Mar; 170(3):709-15.
Score: 0.004
-
Impact of contraception on gynecologic cancers. Am J Obstet Gynecol. 1993 Jun; 168(6 Pt 2):1980-5.
Score: 0.004
-
Medical conditions among adult offspring prenatally exposed to diethylstilbestrol. Epidemiology. 2013 May; 24(3):430-8.
Score: 0.004
-
Prenatal diethylstilbestrol exposure and performance on college entrance examinations. Horm Behav. 1992 Sep; 26(3):433-9.
Score: 0.004
-
The Bethesda system for cervical/vaginal cytologic diagnoses. Clin Obstet Gynecol. 1992 Mar; 35(1):22-7.
Score: 0.003
-
Does early exposure to maternal smoking affect future fertility in adult males? Reprod Toxicol. 1992; 6(4):297-307.
Score: 0.003
-
Mammography screening behaviors of women exposed prenatally to diethylstilbestrol. J Womens Health (Larchmt). 2012 Feb; 21(2):209-14.
Score: 0.003
-
Adverse health outcomes in women exposed in utero to diethylstilbestrol. N Engl J Med. 2011 Oct 06; 365(14):1304-14.
Score: 0.003
-
Concerns regarding the Bethesda System. Int J Gynecol Pathol. 1991; 10(4):326-8.
Score: 0.003
-
Clear cell adenocarcinoma of the lower genital tract. Correlation of mother's recall of diethylstilbestrol history with obstetrical records. Cancer. 1990 Nov 15; 66(10):2215-20.
Score: 0.003
-
Estimates of dose to intraperitoneal micrometastases from alpha and beta emitters in radioimmunotherapy. Gynecol Oncol. 1990 Sep; 38(3):478-85.
Score: 0.003
-
The Bethesda System for cervical/vaginal cytologic diagnoses: a note of caution. Obstet Gynecol. 1990 Sep; 76(3 Pt 1):449-50.
Score: 0.003
-
Medical professional liability and obstetric care: the Institute of Medicine report and recommendations. Obstet Gynecol. 1990 Apr; 75(4):705-9.
Score: 0.003
-
Preoperative radiotherapy followed by radical vulvectomy with inguinal lymphadenectomy for advanced vulvar carcinomas. Gynecol Oncol. 1990 Feb; 36(2):181-4.
Score: 0.003
-
Clear cell adenocarcinoma of the vagina and cervix secondary to intrauterine exposure to diethylstilbestrol. Semin Surg Oncol. 1990; 6(6):343-6.
Score: 0.003
-
Comparison of short-lived high-LET alpha-emitting radionuclides lead-212 and bismuth-212 to low-LET X-rays on ovarian carcinoma. Gynecol Oncol. 1989 Dec; 35(3):297-300.
Score: 0.003
-
Breast biopsy techniques. Clin Obstet Gynecol. 1989 Dec; 32(4):800-6.
Score: 0.003
-
Vinblastine, cisplatin, cyclophosphamide, bleomycin, doxorubicin, and etoposide in the treatment of small cell carcinoma of the ovary. Cancer. 1989 Sep 15; 64(6):1183-7.
Score: 0.003
-
Pelvic exenteration in clear cell adenocarcinoma of the vagina and cervix. Gynecol Oncol. 1989 Sep; 34(3):413-6.
Score: 0.003
-
Urogenital abnormalities in men exposed to diethylstilbestrol in utero: a cohort study. Environ Health. 2009 Aug 18; 8:37.
Score: 0.003
-
Infections and antibiotic prophylaxis in reconstructive vascular surgery. Eur J Vasc Surg. 1989 Aug; 3(4):303-7.
Score: 0.003
-
Breast cancer screening in women exposed in utero to diethylstilbestrol. J Womens Health (Larchmt). 2009 Apr; 18(4):547-52.
Score: 0.003
-
The development of alpha-emitting radionuclide lead 212 for the potential treatment of ovarian carcinoma. Am J Obstet Gynecol. 1989 Apr; 160(4):789-97.
Score: 0.003
-
An evaluation of stage II vaginal clear cell adenocarcinoma according to substages. Gynecol Oncol. 1988 Sep; 31(1):56-64.
Score: 0.003
-
Cervical screening and general physical examination behaviors of women exposed in utero to diethylstilbestrol. J Low Genit Tract Dis. 2008 Apr; 12(2):111-7.
Score: 0.003
-
Infertility among daughters either exposed or not exposed to diethylstilbestrol. Am J Obstet Gynecol. 1988 Mar; 158(3 Pt 1):493-8.
Score: 0.003
-
Offspring of women exposed in utero to diethylstilbestrol (DES): a preliminary report of benign and malignant pathology in the third generation. Epidemiology. 2008 Mar; 19(2):251-7.
Score: 0.003
-
Overview of therapeutic and prophylactic antibiotics in obstetrics and gynecology. J Reprod Med. 1988 Jan; 33(1 Suppl):144-8.
Score: 0.003
-
Evaluation of bolus cis-platinum and continuous 5-fluorouracil infusion for metastatic and recurrent squamous cell carcinoma of the cervix. Gynecol Oncol. 1988 Jan; 29(1):76-81.
Score: 0.003
-
Local therapy in stage I clear cell adenocarcinoma of the vagina. Cancer. 1987 Sep 15; 60(6):1319-24.
Score: 0.003
-
Secondary sex ratio among women exposed to diethylstilbestrol in utero. Environ Health Perspect. 2007 Sep; 115(9):1314-9.
Score: 0.003
-
An evaluation of squamous cell carcinoma antigen in patients with cervical squamous cell carcinoma. Am J Obstet Gynecol. 1987 Aug; 157(2):433-9.
Score: 0.003
-
Cancer risk in women prenatally exposed to diethylstilbestrol. Int J Cancer. 2007 Jul 15; 121(2):356-60.
Score: 0.003
-
Preeclampsia risk in women exposed in utero to diethylstilbestrol. Obstet Gynecol. 2007 Jul; 110(1):113-20.
Score: 0.003
-
Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update. N Engl J Med. 1987 Feb 26; 316(9):514-6.
Score: 0.002
-
Shorter remission period in young versus older children with diabetes mellitus type 1. Exp Clin Endocrinol Diabetes. 2007 Jan; 115(1):33-7.
Score: 0.002
-
The effects in the human of diethylstilbestrol (DES) use during pregnancy. Princess Takamatsu Symp. 1987; 18:67-75.
Score: 0.002
-
Age at natural menopause in women exposed to diethylstilbestrol in utero. Am J Epidemiol. 2006 Oct 01; 164(7):682-8.
Score: 0.002
-
Prenatal diethylstilbestrol exposure and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2006 Aug; 15(8):1509-14.
Score: 0.002
-
Mortality in women given diethylstilbestrol during pregnancy. Br J Cancer. 2006 Jul 03; 95(1):107-11.
Score: 0.002
-
Birth weight and breast cancer risk. Br J Cancer. 2006 Jun 05; 94(11):1734-7.
Score: 0.002
-
Clear cell adenocarcinoma (CCA) of the vagina and cervix in association with pregnancy. Gynecol Oncol. 1986 Jun; 24(2):207-19.
Score: 0.002
-
Menstrual and reproductive characteristics of women whose mothers were exposed in utero to diethylstilbestrol (DES). Int J Epidemiol. 2006 Aug; 35(4):862-8.
Score: 0.002
-
Risk factors for the development of diethylstilbestrol-associated clear cell adenocarcinoma: a case-control study. Am J Obstet Gynecol. 1986 Apr; 154(4):814-22.
Score: 0.002
-
Hexamethylmelamine, cyclophosphamide, adriamycin, cis-platinum chemotherapy as initial and second-line treatment of advanced ovarian carcinoma. Oncology. 1986; 43(1):12-7.
Score: 0.002
-
Hypospadias in sons of women exposed to diethylstilbestrol in utero. Epidemiology. 2005 Jul; 16(4):583-6.
Score: 0.002
-
Persistence and distribution of estrogen receptor in advanced epithelial ovarian carcinoma after chemotherapy. Obstet Gynecol. 1985 Feb; 65(2):257-63.
Score: 0.002
-
Risk of benign gynecologic tumors in relation to prenatal diethylstilbestrol exposure. Obstet Gynecol. 2005 Jan; 105(1):167-73.
Score: 0.002
-
Diethylstilbestrol exposure--1984. N Engl J Med. 1984 Nov 29; 311(22):1433-5.
Score: 0.002
-
The effect of lithium carbonate on chemotherapy-induced neutropenia and thrombocytopenia. Am J Hematol. 1984 May; 16(4):313-23.
Score: 0.002
-
Nuclear DNA content of clear cell adenocarcinoma of the vagina and cervix and its relationship to prognosis. Gynecol Oncol. 1983 Apr; 15(2):230-8.
Score: 0.002
-
Accuracy of three sampling technics for the diagnosis of endometrial cancer and hyperplasias. J Reprod Med. 1982 Oct; 27(10):622-6.
Score: 0.002
-
Risk of breast cancer in women exposed to diethylstilbestrol in utero: prelimiinary results (United States). Cancer Causes Control. 2002 Oct; 13(8):753-8.
Score: 0.002
-
DES-related female genital changes. Semin Oncol. 1982 Sep; 9(3):341-8.
Score: 0.002
-
Medical treatment of urethral prolapse in children. Obstet Gynecol. 1982 Jan; 59(1):69-74.
Score: 0.002
-
Reproductive and gynecologic surgical experience in diethylstilbestrol-exposed daughters. Am J Obstet Gynecol. 1981 Dec 15; 141(8):1019-28.
Score: 0.002
-
Diethylstilbestrol and other sex hormones during pregnancy. Obstet Gynecol. 1981 Nov; 58(5 Suppl):35S-40S.
Score: 0.002
-
Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States). Cancer Causes Control. 2001 Nov; 12(9):837-45.
Score: 0.002
-
Infertility among women exposed prenatally to diethylstilbestrol. Am J Epidemiol. 2001 Aug 15; 154(4):316-21.
Score: 0.002
-
Estrogen receptor and peroxidase activity in epithelial ovarian carcinomas. J Natl Cancer Inst. 1981 Aug; 67(2):307-18.
Score: 0.002
-
Clear cell adenocarcinoma and the current status of DES-exposed females. Cancer. 1981 Jul 15; 48(2 Suppl):484-8.
Score: 0.002
-
Intrauterine infection may be a major cause of stillbirth in Sweden. Acta Obstet Gynecol Scand. 2001 Jun; 80(6):511-8.
Score: 0.002
-
Cancer risk in men exposed in utero to diethylstilbestrol. J Natl Cancer Inst. 2001 Apr 04; 93(7):545-51.
Score: 0.002
-
Long-term cancer risk in women given diethylstilbestrol (DES) during pregnancy. Br J Cancer. 2001 Jan 05; 84(1):126-33.
Score: 0.002
-
The current status of the DES-exposed population. Obstet Gynecol Annu. 1981; 10:267-78.
Score: 0.002
-
DES update. Interview by Arthur I. Holleb. CA Cancer J Clin. 1980 Nov-Dec; 30(6):326-32.
Score: 0.002
-
Continued follow-up of pregnancy outcomes in diethylstilbestrol-exposed offspring. Obstet Gynecol. 2000 Oct; 96(4):483-9.
Score: 0.002
-
A comparison of pregnancy experience in DES-exposed and DES-unexposed daughters. J Reprod Med. 1980 Feb; 24(2):62-9.
Score: 0.002
-
Epidemiologic aspects and factors related to survival in 384 Registry cases of clear cell adenocarcinoma of the vagina and cervix. Am J Obstet Gynecol. 1979 Dec 01; 135(7):876-86.
Score: 0.001
-
Coitus and the fetus. N Engl J Med. 1979 Nov 29; 301(22):1235-6.
Score: 0.001
-
DES-associated clear cell adenocarcinoma of the vagina and cervix. Obstet Gynecol Surv. 1979 Nov; 34(11):844.
Score: 0.001
-
A correlative nuclear DNA and histologic study of genital squamous lesions in DES exposed progeny. Obstet Gynecol Surv. 1979 Nov; 34(11):849-50.
Score: 0.001
-
Assessment of three sampling technics to detect endometrial cancer and its precursors. A preliminary report. Acta Cytol. 1979 Sep-Oct; 23(5):353-9.
Score: 0.001
-
Prenatal diethylstilbestrol exposure and human genital tract abnormalities. Natl Cancer Inst Monogr. 1979 May; (51):25-35.
Score: 0.001
-
An analysis of 346 cases of clear cell adenocarcinoma of the vagina and cervix with emphasis on recurrence and survival. Gynecol Oncol. 1979 Apr; 7(2):111-22.
Score: 0.001
-
Remission of uterine leiomyosarcomas treated with vincristine, Adriamycin, and dimethyl-triazeno-imidazole carboximide. Am J Obstet Gynecol. 1979 Feb 15; 133(4):379-81.
Score: 0.001
-
Preoperative intracavitary brachytherapy in early-stage cervical carcinoma. Am J Clin Oncol. 1999 Feb; 22(1):73-7.
Score: 0.001
-
Complications of prenatal therapy with diethylstilbestrol. Pediatrics. 1978 Dec; 62(6 Pt 2):1151-9.
Score: 0.001
-
Comparison of histologic and colposcopic findings in DES-exposed females. Obstet Gynecol. 1978 Oct; 52(4):457-61.
Score: 0.001
-
A twenty-five-year follow-up study of women exposed to diethylstilbestrol during pregnancy. N Engl J Med. 1978 Apr 06; 298(14):763-7.
Score: 0.001
-
Evaluation and management of diethylstilbestrol-exposed offspring. Surg Clin North Am. 1978 Feb; 58(1):87-96.
Score: 0.001
-
Pathology of prenatal diethylstilbestrol exposure. Pathol Annu. 1978; 13 Pt 1:201-16.
Score: 0.001
-
Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix. Am J Obstet Gynecol. 1977 May 01; 128(1):43-50.
Score: 0.001
-
Epidemiology of vaginal adenosis and adenocarcinoma associated with exposure to stilbestrol in utero. Cancer. 1977 Apr; 39(4 Suppl):1892-5.
Score: 0.001
-
Intrauterine diethylstilbestrol exposure and its consequences: pathologic characteristics of vaginal adenosis, clear cell adenocarcinoma, and related lesions. Arch Pathol Lab Med. 1977 Jan; 101(1):1-5.
Score: 0.001
-
Cytology of 575 young women with prenatal exposure to diethylstilbestrol. Obstet Gynecol. 1976 Nov; 48(5):511-5.
Score: 0.001
-
Angiographic control of pelvic bleeding from treated carcinoma of the cervix. Gynecol Oncol. 1976 Jun; 4(2):144-50.
Score: 0.001
-
Summary of the changes in the human female genital tract as a consequence of maternal diethylstilbestrol therapy. J Toxicol Environ Health Suppl. 1976; 1:13-20.
Score: 0.001
-
Vaginal adenosis and other diethylstilbestrol-related abnormalities. Clin Obstet Gynecol. 1975 Sep; 18(3):185-94.
Score: 0.001
-
Editorial: Problems in the examination of the DES-exposed female. Obstet Gynecol. 1975 Sep; 46(3):353-5.
Score: 0.001
-
Pathology of vaginal and cervical abnormalities associated with prenatal exposure to diethylstilbestrol (des). J Reprod Med. 1975 Jul; 15(1):13-18.
Score: 0.001
-
The significance of adenosis and clear-cell adenocarcinoma of the genital tract in young females. J Reprod Med. 1975 Jul; 15(1):5-11.
Score: 0.001
-
Prenatal exposure to stilbestrol. A prospective comparison of exposed female offspring with unexposed controls. N Engl J Med. 1975 Feb 13; 292(7):334-9.
Score: 0.001
-
Delayed disease as a consequence of fetal exposure to radiation, infection, and exogenous hormones. Clin Perinatol. 1974 Sep; 1(2):483-90.
Score: 0.001
-
Vaginal and cervical abnormalities, including clear-cell adenocarcinoma, related to prenatal exposure to stilbestrol. Ann Clin Lab Sci. 1974 Jul-Aug; 4(4):222-33.
Score: 0.001
-
Clear-cell adenocarcinoma of the vagina and cervix in girls: analysis of 170 registry cases. Am J Obstet Gynecol. 1974 Jul 01; 119(5):713-24.
Score: 0.001
-
Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop. JAMA. 1994 Jun 15; 271(23):1866-9.
Score: 0.001
-
The effects of local progesterone on stilbestrol-associated vaginal adenosis. Am J Obstet Gynecol. 1974 Mar 01; 118(5):607-15.
Score: 0.001
-
Exogenous hormones in pregnancy. Clin Obstet Gynecol. 1973 Dec; 16(4):37-50.
Score: 0.001
-
Avoiding serious infections associated with abdominal hysterectomy: a meta-analysis of antibiotic prophylaxis. Am J Obstet Gynecol. 1993 Nov; 169(5):1119-24.
Score: 0.001
-
Clear-cell adenocarcinoma of the genital tract in young females. Registry report. N Engl J Med. 1972 Dec 21; 287(25):1259-64.
Score: 0.001
-
Stilbestrol and vaginal cancer in young women. CA Cancer J Clin. 1972 Sep-Oct; 22(5):292-5.
Score: 0.001
-
Vaginal and cervical abnormalities after exposure to stilbestrol in utero. Obstet Gynecol. 1972 Sep; 40(3):287-98.
Score: 0.001
-
Stilbestrol-adenosis-carcinoma syndrome: geographic distribution. N Engl J Med. 1971 Sep 16; 285(12):691.
Score: 0.001
-
Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med. 1971 04 22; 284(15):878-81.
Score: 0.001
-
Adenocarcinoma of the vagina in adolescence. A report of 7 cases including 6 clear-cell carcinomas (so-called mesonephromas). Cancer. 1970 Apr; 25(4):745-57.
Score: 0.001
-
Primary carcinoma of the vagina. An analysis of 68 cases. Am J Obstet Gynecol. 1970 Jan 15; 106(2):210-8.
Score: 0.001
-
Comparison of the quantity of estrogen receptors in human endometrium and myometrium by steroid-binding assay and enzyme immunoassay based on monoclonal antibodies to human estrophilin. Am J Obstet Gynecol. 1989 Mar; 160(3):592-7.
Score: 0.001
-
The effect of the alpha-emitting radionuclide lead-212 on human ovarian carcinoma: a potential new form of therapy. Gynecol Oncol. 1989 Feb; 32(2):236-9.
Score: 0.001
-
[Familial progressive myoclonus epilepsy (Unverricht/Lundborg)]. Psychiatr Neurol Med Psychol Beih. 1967; 6:18-39.
Score: 0.001
-
Hyperthyroidism during pregnancy. N Engl J Med. 1965 Sep 16; 273(12):627-33.
Score: 0.001
-
Immunocytochemical identification of estrogen receptor in ovarian carcinomas. Localization with monoclonal estrophilin antibodies compared with biochemical assays. Lab Invest. 1985 Sep; 53(3):349-61.
Score: 0.001
-
Immunohistochemical assessment of estrogen receptor distribution in the human endometrium throughout the menstrual cycle. Lab Invest. 1984 Nov; 51(5):495-503.
Score: 0.001
-
Atypical vaginal adenosis and cervical ectropion. Association with clear cell adenocarcinoma in diethylstilbestrol-exposed offspring. Cancer. 1984 Sep 01; 54(5):869-75.
Score: 0.001
-
A quality-control procedure on cervical lesions for the comparison of cytology and histology. J Reprod Med. 1983 Dec; 28(12):811-22.
Score: 0.000
-
Combined antithyroid-thyroid therapy of hyperthyroidism in pregnancy. Obstet Gynecol. 1963 May; 21:543-50.
Score: 0.000
-
Topographic relation of cervical ectropion and vaginal adenosis to clear cell adenocarcinoma. Obstet Gynecol. 1982 Nov; 60(5):546-51.
Score: 0.000
-
Clear cell adenocarcinoma of the vagina and cervix in black females. J Natl Med Assoc. 1982 Jul; 74(7):639-43.
Score: 0.000
-
Design and preliminary observations of National Cooperative Diethylstilbestrol Adenosis (DESAD) Project. Obstet Gynecol. 1978 Apr; 51(4):453-8.
Score: 0.000
-
Vaginal and cervical cancers and other abnormalities associated with exposure in utero to diethylstilbestrol and related synthetic hormones. Cancer Res. 1977 Apr; 37(4):1249-51.
Score: 0.000
-
Clear-cell adenocarcinoma of the vagina and cervix in young females: analysis of 37 tumors that persisted or recurred after primary therapy. Cancer. 1974 Sep; 34(3):606-14.
Score: 0.000
-
Cytology of clear-cell adenocarcinoma of genital tract in young females: review of 95 cases from the registry. Acta Cytol. 1974 Jul-Aug; 18(4):279-90.
Score: 0.000
-
Familial hyperthecosis: comparison of endocrinologic and histologic findings with polycystic ovarian disease. Am J Obstet Gynecol. 1973 Dec 01; 117(7):976-82.
Score: 0.000
-
Registry of clear-cell carcinoma of genital tract in young women. N Engl J Med. 1971 Aug 12; 285(7):407.
Score: 0.000